Nordic smallpox vaccine approved for monkeypox.
The Department of Health and Human Services announced on Monday that they have ordered 36,000 monkeypox vaccine doses to add to their U.S. vaccine stockpile. This will be in addition to the 36,000 doses already in the Strategic National Stockpile. The vaccine is called Jynneos and will be made by the manufacturer Bavarian Nordic. It is approved to treat both monkeypox and smallpox.
Bavarian Nordic, based in Denmark, originally developed the vaccine with the support of the HHS’ Biomedical Advanced Research and Development Authority and has more than 1 million doses of Jynneos still available. Since June 3, the HHS has administered 1,200 vaccine doses to prevent the spread of monkeypox.
As the Lord Leads, Pray with Us…
- For Secretary Becerra to seek God’s wisdom as he manages the National Strategic Stockpile.
- For discernment HHS officials as they collect and evaluate data on monkeypox.
- For the president and his healthcare advisors to be led by the Lord as they address public health threats.
Sources: The Hill, Reuters
